Zahra Zandi

Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)

Bahareh Kashani, Zahra Zandi, Davood Bashash et al. · Cancer Chemotherapy and Pharmacology · 2019 · 55 citations

Medicine, Immunology, New Insight +9

TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition

Zahra Zandi, Bahareh Kashani, Ensieh M. Poursani et al. · European Journal of Pharmacology · 2019 · 54 citations

Cancer Immunosurveillance, T-regulatory Cell, Breast Cancer Cells +11

The anticancer effect of the TLR4 inhibition using TAK‐242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer

Zahra Zandi, Bahareh Kashani, Davood Bashash et al. · Journal of Cellular Biochemistry · 2019 · 38 citations

Breast Oncology, Immunology, Immunoediting +22

Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway

Ali Nasrollahzadeh, Davood Bashash, Majid Kabuli et al. · Life Sciences · 2020 · 34 citations

Tumor Biology, Breast Oncology, Medicine +8

Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers

Bahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh et al. · Immunologic Research · 2019 · 33 citations

Chemotherapeutic Agents, Breast Oncology, Ovarian Cancers +10